The SAILOR study, the largest trial in exudative AMD to date (n = 4307 ... Mean change in Early Treatment Diabetic Retinopathy Study (ETDRS) letters through 12-month follow-up with 0.5 mg ...
KOD is evaluating tarcocimab in a phase III diabetic retinopathy study, which is set to form the basis for a regulatory ...
SOL-1 is now expected to be enrolled and fully randomized by year-end 2024Topline clinical data from SOL-1 are now expected in Q4 2025BEDFORD, ...
inhibitors reported to be useful for the treatment of atherosclerosis, cancer, pulmonary hypertension, inflammatory bowel disease, influenza, retinopathy, sepsis and wet macular degeneration ...
Although diabetic retinopathy is a leading cause of blindness in adults ... retina with additional oxygen and nutrients.But the extra perfusion might worsen wet, exudative AMD, causing the leaky blood ...
New Delhi: The Vitreo Retinal Society of India (VRSI) and Research Society for the Study of Diabetes in India (RSSDI) announced the jointly formulated Diabetic Retinopathy Screening guidelines ...
The diabetic retinopathy severity scale (DRSS) is a 13-step scale. Healthcare professionals can use the DRSS to measure the severity of diabetic retinopathy in people with diabetes. Diabetic ...
This article evaluates the currently used treatment regimens in ocular anti-VEGF therapy for exudative age-related macular degeneration. Anti-VEGF therapies using variable injection regimens and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback